Cargando…
Supply and Clinical Application of Actinium-225 and Bismuth-213
The recent development of (225)Ac-PSMA617 for therapy of prostate cancer has strikingly demonstrated the clinical potential of targeted alpha therapy. Further promising applications of the alpha emitters (225)Actinium and its daughter nuclide (213)Bismuth include the therapy of brain tumors, bladder...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
W.B. Saunders
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7082773/ https://www.ncbi.nlm.nih.gov/pubmed/32172796 http://dx.doi.org/10.1053/j.semnuclmed.2020.02.003 |